Scolaris Content Display Scolaris Content Display

Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma

Esta versión no es la más reciente

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To assess the efficacy and safety of adding a long‐acting muscarinic agonist (LAMA) to any dose of inhaled corticosteroids (ICS) compared with increasing the dose of ICS for adults whose asthma is not well controlled.